Recent Medical and Health Science News Stories

How Do These White Blood Cells Shape Bowel Health and Disease?

Written by Staff | August 03, 2026

Welcome to Science Snapshot, a quick digest of the latest research happening across the CU Anschutz campus. Hear from researchers as they briefly explain one of their recent studies and how it could improve healthcare. In this installment, we highlight how white blood cells called neutrophils influence bowel health and disease and if a specialized MRI could length pancreatic cancer survival.

 

Neutrophils: A Key to Understanding Inflammatory Bowel Disease?

Researcher: Ian Cartwright, PhD

Division: Gastroenterology and Hepatology

 

What did you study?

This review examined the role of neutrophils (PMN), a type of white blood cell, in intestinal inflammation and inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. PMN are among the first immune cells to arrive at sites of infection or injury, but their effects on the surrounding tissue are more complex than previously appreciated. The review summarizes current research on how PMN alter the local tissue environment during inflammation.

What were you looking for?

The goal was to better understand how PMN influence the intestinal microenvironment during inflammation. While PMN are essential for fighting infections, excessive or prolonged PMN activity can contribute to tissue damage and chronic disease. The goal of the review was to summarize current research into how PMN can both protect and harm the intestine, and what factors determine whether they promote healing or worsen inflammation.

What did you find?

PMN play a dual role in intestinal health. On one hand, they help eliminate harmful microbes, maintain barrier defenses and support tissue repair. On the other hand, when PMN remain activated for too long, they release reactive molecules, enzymes and inflammatory signals that can damage the intestinal lining, alter the microbiome and perpetuate chronic inflammation. The balance between these protective and harmful activities appears to be a key factor in determining disease outcomes.

What is one key takeaway you would like people to know about this research?

PMN are not simply “good” or “bad” cells. They are essential defenders of intestinal health, but when their responses become dysregulated, they can contribute to diseases such as IBD. Understanding how PMN shape the intestinal microenvironment may help researchers develop therapies that preserve their protective functions while limiting the tissue damage that drives chronic inflammation.

 


Advanced Imaging Could Help Extend Pancreatic Cancer Survival

Researcher: Atsushi Oba, MD, PhD

Department: Surgery

 

What was studied?

Atsushi Oba, MD, PhD, and colleagues analyzed data from nearly 40,000 patients with pancreatic cancer treated in Japan over a 10-year period. They examined whether adding a specialized liver MRI called EOB-MRI influenced treatment decisions and outcomes.

What were you looking for?

The team wanted to know whether detecting tiny liver metastases earlier could help physicians choose the most appropriate treatment for patients with pancreatic cancer.

What did you find?

Patients who underwent EOB-MRI were more likely to receive treatment strategies tailored to the extent of their disease and experienced longer overall survival compared with similar patients who did not undergo the specialized liver MRI.

What is one key takeaway?

The better we understand where cancer has spread before treatment begins, the better we can match patients with the right therapy. Advanced imaging may help avoid ineffective treatments and improve outcomes.